WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Value (MSEK)
90,2

Board

CEO

  • Anders Rabbe

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,96 10,96 2021-03-31
Nordnet Pensionsförsäkring 5,87 5,87 2021-03-31
Linfan Zhang 3,76 3,76 2021-03-31
Kjell Stenberg 2,67 2,67 2021-03-31
Tommy Andersson 1,74 1,74 2021-03-31
Gunvald Berger 1,28 1,28 2021-03-31
Lars-Erik Forsgårdh 1,20 1,20 2021-03-31
Niclas Evertsson 0,82 0,82 2021-03-31
Thomas Mellqvist 0,73 0,73 2021-03-31
Eddie Jalmestam 0,67 0,67 2021-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2021-05-06 Årsstämma 2020

  • 2021-05-06 Delårsrapport 2021-Q1

  • 2021-08-19 Delårsrapport 2021-Q2

  • 2021-11-18 Delårsrapport 2021-Q3

  • 2022-02-24 Bokslutskommuniké 2021